CLINICAL TRIALS PROFILE FOR LABETALOL HYDROCHLORIDE

All Clinical Trials for Labetalol Hydrochloride

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000291 ↗	Effects of Labetalol on Human Cocaine Use - 8	Completed	University of Minnesota	Phase 2	1997-10-01	The purpose of this study is to determine the effect of labetalol treatment on the subjective and physiological effects of cocaine.
NCT00000291 ↗	Effects of Labetalol on Human Cocaine Use - 8	Completed	University of Minnesota - Clinical and Translational Science Institute	Phase 2	1997-10-01	The purpose of this study is to determine the effect of labetalol treatment on the subjective and physiological effects of cocaine.
NCT00000291 ↗	Effects of Labetalol on Human Cocaine Use - 8	Completed	National Institute on Drug Abuse (NIDA)	Phase 2	1997-10-01	The purpose of this study is to determine the effect of labetalol treatment on the subjective and physiological effects of cocaine.
NCT00000297 ↗	Effects of Labetalol on Nicotine Administration in Humans - 14	Completed	University of Minnesota	Phase 2	1998-10-01	The purpose of this study is to investigate the effects of labetalol in response to intravenous nicotine
NCT00000297 ↗	Effects of Labetalol on Nicotine Administration in Humans - 14	Completed	University of Minnesota - Clinical and Translational Science Institute	Phase 2	1998-10-01	The purpose of this study is to investigate the effects of labetalol in response to intravenous nicotine
NCT00000297 ↗	Effects of Labetalol on Nicotine Administration in Humans - 14	Completed	National Institute on Drug Abuse (NIDA)	Phase 2	1998-10-01	The purpose of this study is to investigate the effects of labetalol in response to intravenous nicotine
NCT00007592 ↗	Hypertension Screening and Treatment Program	Completed	US Department of Veterans Affairs		1989-06-01	Hypertension is one of the most common medical problems in the United States and in the VA health care system. It has been well-documented that hypertension can be effectively treated. However, there remain important unresolved clinical questions in the area of antihypertensive treatment. For example, how much is mortality affected by visit compliance, blood pressure control and type of antihypertensive agent? Or, are some regimens associated with more morbidity than others? Or, are there inexpensive regimens that are as effective as more expensive regimens? The amount of data that is available from this demonstration project (currently 6,100 patients) will help address these questions. The answers to these questions should result in better care for veterans with hypertension.

Clinical Trial Conditions for Labetalol Hydrochloride

Condition Name

Condition Name for Labetalol Hydrochloride
Intervention	Trials
Hypertension in Pregnancy	7
Preeclampsia	6
Hypertension	6
Hypertension, Pregnancy-Induced	3

Condition MeSH

Condition MeSH for Labetalol Hydrochloride
Intervention	Trials
Hypertension	22
Pre-Eclampsia	21
Hypertension, Pregnancy-Induced	15
Eclampsia	8

Clinical Trial Locations for Labetalol Hydrochloride

Trials by Country

Trials by Country for Labetalol Hydrochloride
Location	Trials
United States	38
Egypt	11
Canada	7
China	2
Pakistan	2

Trials by US State

Trials by US State for Labetalol Hydrochloride
Location	Trials
New York	11
California	4
Ohio	4
Texas	3
Tennessee	3

Clinical Trial Progress for Labetalol Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Labetalol Hydrochloride
Clinical Trial Phase	Trials
Phase 4	23
Phase 3	6
Phase 2/Phase 3	2

Clinical Trial Status

Clinical Trial Status for Labetalol Hydrochloride
Clinical Trial Phase	Trials
Completed	28
Recruiting	12
Unknown status	8

Clinical Trial Sponsors for Labetalol Hydrochloride

Sponsor Name

Sponsor Name for Labetalol Hydrochloride
Sponsor	Trials
Weill Medical College of Cornell University	3
University of Alberta	3
Mansoura University	3

Sponsor Type

Sponsor Type for Labetalol Hydrochloride
Sponsor	Trials
Other	81
U.S. Fed	4
NIH	4